NDC50419-0190-10 — DIATRIZOATE MEGLUMINE AND DIATRI

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC50419-0190-10: DIATRIZOATE MEGLUMINE AND DIATRI.

DIATRIZOATE MEGLUMINE AND DIATRI. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, therapeutic_equivalent: BERLEX IMAGING DIV., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 20, primary_container_content_quantity: 100.000 MILLILITERS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-230-7171, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC50419-0190-10

NSN: 6505-01-230-7171
FSC: 6505 — Drugs and Biologicals
CAGE: 59463 — BAYER HEALTHCARE PHARMACEUTICALS INC DBA BAYER HEALTHCARE PHARMACEUTICALS INC (USA)

SPECIFICATIONS

administration	INTRAVENOUS
primary_container_type	VIAL
therapeutic_equivalent	BERLEX IMAGING DIV.
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	20
primary_container_content_quantity	100.000 MILLILITERS
active_medicament_medicinal_strength	10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
NSN	6505-01-230-7171

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: BERLEX IMAGING DIV.

•

ADMINISTRATION: INTRAVENOUS

•

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT

•

TOTAL PRIMARY CONTAINER QUANTITY: 20

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	BERLEX IMAGING DIV.
ADMINISTRATION	INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY	100.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL
ACTIVE MEDICAMENT MEDICINAL STRENGTH	10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY	20

SUBSTITUTES & CROSS-REFERENCES 1

ANGIOVIST 370Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC50419-0190-10?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC50419-0190-10?

NDC50419-0190-10 is a DIATRIZOATE MEGLUMINE AND DIATRI.

What parts can replace NDC50419-0190-10?

There is 1 known substitute for NDC50419-0190-10: ANGIOVIST 370. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC50419-0190-10?

NDC50419-0190-10 is cataloged in the U.S. Government catalog under NSN 6505-01-230-7171. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC50419-0190-10 — DIATRIZOATE MEGLUMINE AND DIATRI

Request a Quote — NDC50419-0190-10